Amount Raised
$45.1 Million
Round Type
Grant
Salt Lake CityBiotechnologyTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Clene Inc. has received a four-year NIH grant totaling $45.1 million to support an Expanded Access Program for CNM-Au8® treatment of amyotrophic lateral sclerosis. The funding will be allocated through several subawards to partner institutions, including Columbia University and New York University. This grant underscores the collaboration between Clene and these institutions to advance treatment options for ALS patients
Quick answer
Clene Nanomedicine raised $45.1 Million in a Grant round, dated October 15, 2023. Investors: New York University, Columbia University and National Institute Of Health. Clene Nanomedicine is based in Salt Lake City, Utah, United States.
- How much did Clene Nanomedicine raise?
- Clene Nanomedicine raised $45.1 Million in a Grant round on October 15, 2023.
- Who invested in Clene Nanomedicine?
- New York University, Columbia University and National Institute Of Health are named as investors in this round.
- What does Clene Nanomedicine do?
- Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and..
- Where is Clene Nanomedicine based and how big is it?
- Clene Nanomedicine is based in Salt Lake City, Utah, United States. Fundz records about 78 employees.
- Who are the decision-makers at Clene Nanomedicine?
- Fundz holds 1 contact at Clene Nanomedicine, including the Vice President, Translational Medicine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Clene Nanomedicine that raised within 45 days of this round, from Fundz verified event records.
- Forward Therapeutics raised $50M (Series A) on November 8, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
- Acasti raised $7.5M on September 25, 2023.
- Entero Therapeutics raised $1.5M (Seed) on September 14, 2023.
- DalCor Pharmaceuticals raised $80M (Series D) on September 13, 2023.
Who to call at Clene Nanomedicine, and when
A new round usually means Clene Nanomedicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Clene Nanomedicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clene Nanomedicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clene Nanomedicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clene Nanomedicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Clene Nanomedicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.